(1)
Shi, V.; Bhutani, T.; Deleuran, M.; Fonacier, L.; Shumack, S.; Zhang, F.; Cameron, M. C. .; Chan, G. L.; Valdez, H.; Yin, N. Abrocitinib in the Treatment of Moderate-to-Severe Atopic Dermatitis Refractory to Dupilumab Treatment: An Analysis of JADE-EXTEND, a Phase 3 Long-Term Extension Study. J of Skin 2023, 7, s153.